Opus Medical Therapies
PrivateLast Round
Seed Round
Sep 22, 2026
Total Funding Raised
$9.25M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Opus Medical Therapies is a therapeutic devices company that develops and manufactures transcatheter mitral and tricuspid valve replacement products for patients with mitral and tricuspid valve disease.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Sports & Fitness
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Opus Medical Therapies Comparables
Compare Opus Medical Therapies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| InnovHeart | 86% | |
| CroíValve | 86% | |
| Laplace Interventional | 84% |
Opus Medical Therapies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Sep 22, 2026 | ||||
| Early Funding | Sep 4, 2020 | ||||
| Convertible Debt | May 2, 2020 | ||||
| Debt | Aug 19, 2019 |
Key People
Founding team and executive leadership
Opus Medical Therapies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ithaka Partners | Seed |
| Tidewater Investment Company | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 22, 2026
$485K raised in Seed Round.
- Sep 4, 2020
Raised $1.75M in early funding.
Recent news
Latest coverage and updates
- receives_financingOct 8, 2026
Opus Medical Therapies, LLC receives $485K in development capital from undisclosed investors on Sep 22nd '26.
Opus Medical Therapies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Opus Medical Therapies's valuation, stock price, and market status.
Is Opus Medical Therapies a public or private company?
Opus Medical Therapies is a private company.
What is the current stock price of Opus Medical Therapies?
Opus Medical Therapies is a private company, so its shares have no public market price. Caplight tracks Opus Medical Therapies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Opus Medical Therapies worth (valuation)?
Valuation information for Opus Medical Therapies is not publicly available.
Can I buy Opus Medical Therapies stock?
Opus Medical Therapies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Opus Medical Therapies's last funding round?
Opus Medical Therapies's most recent funding round was Seed Round on September 22, 2026.
Who are the main investors in Opus Medical Therapies?
Key investors in Opus Medical Therapies include Ithaka Partners, Tidewater Investment Company.
Will Opus Medical Therapies IPO soon?
No public IPO plans have been announced for Opus Medical Therapies.
How can I track Opus Medical Therapies secondary market activity?
Caplight tracks bids, offers, and trades in Opus Medical Therapies's shares on secondary markets.